1. Podcasts
  2. Unexplainable
  3. What can we do about antibiotic resistance?
Unexplainable

11 Nov 2026 · 24m · 6 chapters

Episode artwork

What can we do about antibiotic resistance?

In short

Antibiotic resistance—how it emerged, why it’s spreading globally, and what can be done beyond “just take antibiotics correctly.”

Guest backgrounds

Mohamed Zaman is a professor of biomedical engineering and global health at Boston University. He wrote Biography of Resistance and directs a Center on Forced Displacement (refugees/migration), studying links between conflict and drug-resistant infections.

Key claims

Resistance isn’t only caused by patient noncompliance; it’s driven by substandard/counterfeit antibiotics, poor diagnostics leading to broad-spectrum use, and misuse during viral outbreaks (e.g., COVID). Conflict-related environmental heavy metals may promote resistance.

Notable examples

Fleming’s 1928 mold story leading to penicillin; WWII mass production; early documentation of penicillin-resistant bacteria in 1942; Fleming’s warning about insufficient dosing. Sweden’s reduced antibiotic use correlates with reduced resistance. Also discussed: AI drug discovery, soil-derived antibiotic dynamics, resistance-inhibiting molecules, phage therapy, and microbiome “colonization resistance.”

Written by AI. May contain mistakes.

Chapters

0:49

Understanding Antibiotic Resistance

Exploration of our reliance on antibiotics and the threat of resistance.

“Amex Corporate connects cards, expenses, and payments to streamline the way you work.”
3:04

The Origins of Antibiotics

The history of antibiotics, focusing on penicillin and its impact during WWII.

“And today on the show, we're doing a book club episode with Mohamed Zaman.”
5:17

The Problem of Resistance

Discussion on how misuse and insufficient access to antibiotics contribute to resistance.

“that we have figured out, science has figured out, solutions to the most serious health problems of our time.”
7:50

Global Health and Antibiotic Resistance

Examining how global inequalities and environmental factors exacerbate antibiotic resistance.

“And when you zoom out to that larger scale, you realize that this isn't a problem that can be fixed by just telling people to make sure they really, really take their antibiotics for the full 10 days.”
10:44

Current State of Antibiotic Resistance

Overview of the escalating issue of antibiotic-resistant infections and implications.

“But issues of antibiotic resistance affect all of us.”
16:02

Addressing Antibiotic Resistance

Exploration of strategies to combat antibiotic-resistant bacteria.

“You do know what happens to people who eat the mold, right?”
A man walking through an airport, asking his phone a question

Ask about this episode

Get the gist, explore an idea or ask about something said.

Claude

On Unexplainable, what are the key points of this episode?

Searching your listening

Transcript

Automatic transcript. May contain errors.

0:00Support for the show comes from TikTok. If you listen to this show, you probably enjoy discovering new things. It is built into the DNA of the show that curiosity is its own reward and that there's always a deeper dive to do. And one place to explore some of the topics we've covered here is TikTok. Whether it's how to forecast volcanic eruptions, strange phenomena that the James Webb Space Telescope picked up near the beginning of time, or a literal deep dive on the ocean's deepest reefs, TikTok has a wealth of fascinating videos just waiting to be discovered. Your next discovery is waiting on TikTok.

0:41Learn more at tiktok.com slash discover more.

0:48Company spending is complex. Managing it should be simple. Amex Corporate connects cards, expenses, and payments to streamline the way you work. Built to simplify, designed to scale. This is Amex Corporate. Get started at go.amex slash Amex Corporate. Terms apply.

1:14We take certain things kind of for granted in modern medicine. Like, let's say you go get your wisdom teeth removed, or you give birth via C-section, or you have basically any kind of surgery. you can assume that while there is always a risk of infection, it is a low risk.

1:31Muhammad Zaman: Our modern medical system is built on controlling infection. It's not just in surgery either. If you get a UTI or a strep throat or an ear infection. All of these things are to a certain extent serious, of course, but they're also manageable, right? We do take it for granted that things heal. We can take these things for granted because we have antibiotics. This whole class of drugs that are able to target and take out the bacteria that make us sick. And a world where that is not given is quite concerning. For a long time now, people have been worrying about a world without functioning antibiotics.

2:13A world where bacteria no longer respond to our drugs because they have developed antibiotic resistance. Years ago, Mohamed Zaman, a professor of biomedical engineering and global health at Boston University, he became one of the people who was thinking about this problem.

2:32Muhammad Zaman: I recognize that to really understand antibiotic resistance, one has to understand why does it happen? Where does it come from? What exactly are the drivers? And assuming that it's purely, I don't know, a lab issue or a science issue, doesn't do justice to the complexity of the problem. That's why he wound up writing a book called Biography of Resistance, a book that dives into the history of antibiotics and then tries to understand their future. So this is Unexplainable. I'm Britt Pinkerton. And today on the show, we're doing a book club episode with Mohamed Zaman.

3:24Humans have been using different kinds of antimicrobials for a long time. But Mohammed starts the story of modern antibiotics where most people do.

3:32Muhammad Zaman: So there's a very famous story of Sir Fleming in England, Alexander Fleming. As the story goes, Alexander Fleming's doing some research, growing bacteria in petri dishes. He goes on vacation for a while, and some mold lands on his experiment. And he comes back and he sees that there's bacteria everywhere on the plate, except where the mold has fallen. Something about that mold was killing bacteria. And that discovery in 1928 eventually led to the antibiotic penicillin. But it did not immediately kick off the modern age of antibiotics. For about a decade, decade and a half, nobody cared. So it was not until the Second World War that it really became a major sort of contributor to public health.

4:25Infections were a serious problem during World War II, and research into penicillin really ramped up.

4:31Muhammad Zaman: And the U.S. really sort of recognizes it and puts in the effort. So it was a massive project. The U.S. War Department eventually poured a ton of resources into finding a way to mass produce enough purified penicillin to treat lots and lots of people. And it made a big splash. There were ads like this one that had a picture of a soldier in a battlefield, and it says, thanks to penicillin, he will come home. Penicillin was called a wonder drug and a miracle drug in newspaper headlines. and then people quickly started finding other antibiotics as well. There's a sense of euphoria, so to speak. There's also the sense that this is an era of great, extraordinary scientific progress that we have figured out, science has figured out, solutions to the most serious health problems of our time.

5:25This one class of drugs was basically like a single scientific solution to so many ailments.

5:33Muhammad Zaman: So this is what we would call the honeymoon period. From mid-1940s to probably early 1960s, people are using it very aggressively. And almost from the very beginning, we start to see the seeds of the problem that we're facing today. In 1942, so during the war, people documented bacteria that were resistant to penicillin. In his Nobel Prize speech in 1945, Fleming warned people of the dangers of bacterial resistance. And now, decades later, even though people have come up with many new antibiotics since penicillin, we are still facing this issue. Bacteria are still becoming resistant. When we think of antibiotic resistance, we often associate it with patient behavior.

6:21Muhammad Zaman: You were supposed to take it for three days, you took it for a day. You were supposed to take it for 10 days, you took it for three days. Alexander Fleming warned people of this particular source of resistance in his Nobel speech, actually. He said, if you use penicillin, use enough. Because if you use enough antibiotics on the bacteria they're intended for, like a high enough dose for long enough, hopefully the antibiotics will be able to wipe out all of the bacteria, even the hardiest ones. But if you take your antibiotics for three days instead of 10, say, they will kill some of the bacteria.

7:00But if there are some bacteria that have just a little resistance, a little more hardiness, those bacteria might survive those first three days. And then on day four, those bacteria can keep on keeping on. They now have no competition from this more susceptible bacteria since the susceptible bacteria are all dead. So those slightly more resistant bacteria reproduce and multiply, leaving you with a whole bunch of bacteria that are more resistant to the drugs you're using against them. It's almost like you're carefully selecting for drug-resistant bacteria in generation after generation. In his book, Mahmoud explains that we do select for drug resistance this way, right?

7:46By not taking our antibiotics for long enough. But his research is in global health. And when you zoom out to that larger scale, you realize that this isn't a problem that can be fixed by just telling people to make sure they really, really take their antibiotics for the full 10 days.

8:05Muhammad Zaman: What if it was not your fault at all? You were a mortal patient. What if you didn't have access to the right drugs? Some of Muhammad's research has looked into substandard or counterfeit drugs, which can include antibiotics. A recent paper acknowledged that there's not a ton of research into the connection between these drugs and antimicrobial resistance. But Mohamed explained that his reason for believing that there might be a problem here is that if the drug you're buying, say, had a lower dose than it was supposed to, or if it wasn't the correct antibiotic, then it might not matter if you took it for the full 10 days.

8:42It still might leave behind resistant bacteria. He also says that diagnosis is a problem here. So if you have access to a medical system with really great diagnostic tools, you can be treated in a pretty targeted way.

8:57Muhammad Zaman: When you and I were very privileged to be able to go and get tested, it will be given a narrow spectrum, a drug that is designed only to kill that bacteria, not a whole bunch of other ones. That's not always the case in the places where Mohamed does some of his research. So in many of these places, what you get is what are called broad-spectrum antibiotics, something that sort of attacks a whole bunch of bacteria because you don't know which one is causing it, right? Which may kill some of the bacteria that's causing the disease, but other ones as well, or not kill them and allow them to become resistant, right?

9:27Muhammad Zaman: So there is that problem that exists in terms of ability to test as well as having the right drug. So you need both hand in hand. Sometimes, because of a lack of access to good testing, people take antibiotics when they don't have a problem that can be treated with antibiotics. Like, antibiotics kill bacteria, not viruses. In COVID, people in Pakistan were taking antibiotics because they don't have the diagnostic that can tell this is actually COVID. This is actually a viral infection. Mohamed also directs a Center on Forced Displacement, so on refugees and migration. And some of his research focuses on how this too connects to drug-resistant infection.

10:11He says conflicts can lead to certain heavy metals being in the environment from weapons being dropped, for example. And there is research showing that heavy metals can promote drug resistance in bacteria.

10:23Muhammad Zaman: So the people who are already impacted by conflict, who are already poor, who are suffering, who are displaced from their homes, now have this added heavy burden in their lives because of drug-resistant infection. From a humanitarian perspective, I would hope that we would all care about people who are impacted by conflicts or who don't have access to accurate diagnostics. But issues of antibiotic resistance affect all of us. Because people travel. People mingle and interact all the time, right? Airports, flights. People go on vacation or ship things around the world. And when we move, our bacteria move with us.

11:01So an antibiotic-resistant bacteria won't stay in one part of the world or respect our borders. So basically, in reading Muhammad's book, I developed a better understanding of just how complex and global the story of antibiotics really is. And we only touched on some aspects of this sort of interconnected problem here. Antibiotic resistance also comes from using them in huge quantities to raise animals for food. and from letting antibiotics run off into our wastewater, among other issues. So how close are we to a world where we can no longer take for granted that we can get a surgery and stop infection?

11:45Or that when we have a UTI, there'll be a solution?

11:48Muhammad Zaman: That's a very hard question to answer, and I don't want to sort of create any kind of misrepresentation. I think we are closer to it than we were 40 years ago or 30 years ago, right? That's what I think is concerning, that we see that there are more people who are impacted. One report found that a little over a million people die from antibiotic-resistant infections a year. And then there's an indirect cost that is about four times as much. For example, you may have co-infections from something else. You may have sepsis. Your infection goes into the bloodstream. Those kinds of things because of failure of antibiotics.

12:23Muhammad Zaman: And that number is about four and a half million. Unfortunately, it is not coming down. And that is, I think, what is concerning, right? That these numbers, as you started counting, are increasing. But Mohamed does not despair. After the break, we'll talk about what we can do about all this.

12:48Support for the show comes from TikTok. Being curious is endlessly rewarding. There are few better feelings, in my opinion, than asking a question and then having that question lead you down a rabbit hole. Might even be the beginning of a new set of interests that was not on your radar beforehand. Maybe you're looking up at the night sky one night and you start to wonder what the most distant thing you can see with the naked eye is. One place to start searching for answers to a question like that is TikTok. First, you might discover a video about the Andromeda galaxy. And then, the next thing you know, you're learning how to find different stars, or how to identify constellations, or how different astronomical discoveries got made, or how constellations got their names.

13:38You don't need serious equipment to make serious discoveries. Start with a simple question, and suddenly, you're somewhere you never expected to be. Your next discovery is waiting on TikTok. Learn more at tiktok.com slash discover more at tiktok.com slash discover more.

14:03Support for the show comes from Bill. When it comes to any project, it's important to leverage tools that you know actually work. That's why if you are managing critical cash flow, you might want to consider using Bill. They say it is the proven tool you can add to your financial tech stack, and 99 of the top 100 U.S. accounting firms and almost half a million customers use Bill. According to their data, Bill has processed over a trillion dollars of secure payments. That is trillion, with a T. Because when it comes to intelligent finance, Bill isn't new to the game. Their massive data network makes it easy to simplify and secure invoice approvals and outgoing payments.

14:48You can say goodbye to manual chores and instead focus on strategic insights and start getting more from your money. You can speak with a payments expert at Bill to see how teams your size are cutting down their workflows. They'll send you a gift card as a thank you. You can claim your gift card at bill.com slash proven. That's bill.com slash proven. Bill delivers scale, not hype. Terms and conditions apply. See offer page for details.

15:41listeners, new customers get$700 credit back. Just search Realize Podcast on Google or use the promo code podcast26. Ready to get started? Take advantage of this offer while it lasts. Terms apply.

16:02You do know what happens to people who eat the mold, right? Keep it together. Just one bite. So, what do you do about a problem like antibiotic-resistant bacteria? My first impulse is to say, make more antibiotics? But that is not happening at the rate that it was back in the 1950s. It is really hard to develop new antibiotics. It's very time-consuming. It's very expensive to figure out which options to test for and then test them. The economic incentives aren't great for pharmaceutical companies. But one possible option here is to try and tackle this development problem with artificial intelligence.

16:43Muhammad Zaman: The idea is faster computation can sort of narrow the list of possible targets in a way that lab experimentation cannot. Let's say you have lots of molecules you think might perhaps make for usable antibiotics. AI tools could help you narrow down, with a little less time and effort, some of the more likely candidates. Instead of trying things for clinical trials in tens of thousands, now you can start with probably 25 or 100 potential drugs which have less risk of failure. Though, Mohamed is clear, there is still a risk of failure here. They can still fail in clinical phase two and three and so on and so forth, right?

17:25Muhammad Zaman: So I think one has to view this as both a potential but not an ultimate solution. So I want to sort of caution against it being another magic bullet. But even if scientists do develop new antibiotics, if we don't change how we use them, then bacteria could just develop resistance to those new antibiotics too, eventually, right? So in his book, Mohamed looks at other research options besides just sort of make more of the same. Research that looks into ways we might help our existing antibiotics last longer. Some of that research involves soil. We actually have gotten lots of antibiotics from soil.

18:10There's lots of fungi and bacteria in there all sort of interacting and competing. And so you have fungi cooking up antibiotics like penicillin that will just wreck a bacterium. And then naturally in the soil as well, you have bacteria figuring out defenses against these attacks, ways to resist the antibiotics that, say, the fungi are producing. They will come up with, say, a cleaver-like enzyme that can chop an antibiotic before it gets the chance to mess them up. But back in 2014, some researchers in Canada found something else in soil, too. They found a molecule that a fungus was making that neutralized that enzyme defense in a bacterium.

18:56So it basically inhibited or sort of turned off the ability of the bacterium to use this particular technique to resist an antibiotic attack. And Jerry Wright, one of the scientists involved, has devoted a lot of time to finding similar inhibitors.

19:12Muhammad Zaman: And this idea, I think, completely circumvents this notion that we need a new antibiotic. If we could find a way to use inhibitors like this to turn off resistance in bacteria, then maybe we could continue to use some of our existing antibiotics for longer. So Mohamed is obviously interested in this and in other ways that we might better understand what's happening in soil in order to find new ways to stretch out our existing antibiotic arsenal. And then he's also curious about the research that's trying to move us away from antibiotics to help us look for something else for a change. So there's several things that are actually really interesting.

19:51Muhammad Zaman: So I'll take a step back, if you allow me, and a discovery that predates antibiotics, and that's actually phages. Phages are viruses, essentially, but viruses that attack bacteria. They actually go into the nerve center of the bacteria and sort of commandeer the machinery and tell the bacteria to kill itself. There was actually research into phages before antibiotics took the world by storm. But at least in the U.S. and in Western Europe, antibiotics wound up sort of taking up a lot of the research attention. Now, though, there's renewed interest in what these viruses might do and how they might help fight off bacterial pathogens for us.

20:32So that could be an option. Or we could also potentially fight off bacteria with bacteria. What if we were able to somehow, instead of antibiotics, give a boost to the good bacteria inside your gut? Not all bacteria are bad for us. In fact, lots of bacteria help us out. They live inside us, do important things for us. And one of those things is called colonization resistance. So basically preventing bad bacteria from taking over.

21:05Muhammad Zaman: And if the good ones somehow had a predisposition of winning this sort of conflict, that would be great. Mohamed is careful to say that researchers still have a long way to go before they can figure out exactly how to boost our microbial biomes to help take on pathogens. We are not there scientifically. We don't fully understand it. There are some early studies demonstrating what could do that, what could give you an advantage. But I think the microbiome science is quite exciting in this regard and promising. So microbiome science, phage science, soil science, AI tools, These are all scientific avenues we might pursue in order to start to untangle our resistance problem here.

21:50But if I've learned one thing from Mohammed's book, it's that the story of antibiotics has never just been about the science. Even at the very beginning of this story, Alexander Fleming's discovery did not take the world by storm until the sort of societal forces of the war led to huge investments. And the problems of antibiotic resistance, too, I think, require more than just new research. They require societal change. We could make sure that more people in the world have access to better medicine and better diagnostic tools. We could make changes in how doctors prescribe antibiotics. Mohamed points to Sweden, for example, where antibiotic use went down and antibiotic resistance went down as a result.

22:38We could change the economic incentives around developing new solutions. We could change regulations around antibiotic use in agriculture. We could ensure that countries coordinate on their approaches, since what happens in one country affects all the rest. We could, Mohamed says, have fewer wars, since his research looks into the ways that they contribute to antibiotic resistance. We could, in short, do a lot of different things. And we will probably have to do a lot of different things. Because antibiotics might have seemed like a miracle drug, but unfortunately, the reality is that there is no single silver scientific bullet out there.

23:22Muhammad Zaman: There is no one-size-fits-all, but I also, I'm optimistic that you don't have to be a scientist or a physician or a philosopher to look at this. This is something that really connects many aspects and many facets of society together.

23:41Mohamed Zaman's book is a biography of resistance. And there is really so much more in there than we were able to touch on today because antibiotic resistance is a huge topic. This episode was produced by me, Brad Pinkerton. It was edited by Meredith Hodnott, who runs the show with Joanna Solotaroff, our editorial director. Christian Ayala did the mixing and the sound design. Noam Hasenfeld does our music. The wonderful Melissa Hirsch checked the facts. Valerie Schenkman, Jacob Reynolds, and Kareem Correa are the facts that honey can have antibacterial properties. And thanks, as always, to Brian Resnick for co-creating the show with me and Noam.

24:20Thanks also to Jerry Wright for taking the time to talk me through his research. If you have thoughts on antibiotic resistance, please email us at unexplainable at Vox.com. If you would like to support the show and the journalism that Vox does, we would love it if you would become a member of Vox. It is very easy to do. Just go to Vox.com slash members. You'll get access to all of Vox's journalism, and you'll know that you're supporting all of Vox's journalism. For those of you who have emailed to let us know that you signed up because of Unexplainable, thank you. That makes a big difference. Thank you also to those of you who have left us a nice review on the podcast platform of your choice or just told someone in your life about the show.

25:02You are all, and I mean this sincerely, the best. Unexplainable is part of the Vox Media Podcast Network, and we will be back very soon with another episode about everything that we do not yet know.

25:25Kate holds the key to every brand asset your business has ever made. She's the only person who knows the difference between teal, turquoise, and the correct company blue. But she's going on vacation. Luckily, before the company falls into design disarray, you realize you can put Kate into Canva. Save every color font and logo to a brand kit everyone can access. And Kate can vacation happily in the knowledge that no one will ever use Comic Sans. What will you Canva today? This is Blue from the UPS Store with a very special holiday announcement for small business owners. We're open! Let's be real.

26:03Your deadlines don't take holidays. So while the other guys are checking out, the UPS Store is here to pack, ship, print, shred, notarize, and check more things off your list all year long. With over 5 ,500 locations, there's a blue near you at the UPS Store. Shredding services are provided by Iron Mountain as is. Visit the upsstore.com slash shredding for full details. Most locations are independently owned. Products, services, prices, and hours of operation may vary. See store for details.

From the publisher

More than 1 million people are estimated to die from drug-resistant infections every year, and that number is rising. But there are some surprising potential solutions in soil, viruses, and even... world peace?

Guest: Muhammad Zaman, author of Biography of Resistance

For show transcripts, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unxtranscripts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unexplainable⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And please email us! ⁠⁠⁠[email protected]⁠⁠⁠We read every email.Support Unexplainable (and get ad-free episodes) by becoming a Vox Member today: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/members⁠⁠⁠⁠⁠⁠⁠⁠Thank you!
Learn more about your ad choices. Visit podcastchoices.com/adchoices

More from Unexplainable

All episodes